In a 35-year-old hypertensive man with a two‑week history of fever, cough, dyspnea (treated with azithromycin), now presenting with bilateral pulmonary consolidations, neutrophilic leukocytosis, elevated C‑reactive protein, anemia (hemoglobin 9 g/dL), acute kidney injury (BUN 85 mg/dL, creatinine 9 mg/dL) with proteinuria, and rapid progression to acute respiratory distress syndrome requiring intubation, what are the differential diagnoses and the most likely diagnosis?

Pulmonary-Renal Syndrome with Rapid Progression to ARDS

This patient most likely has a pulmonary-renal syndrome—specifically anti-GBM disease (Goodpasture syndrome), granulomatosis with polyangiitis (GPA), or systemic lupus erythematosus—rather than community-acquired pneumonia, given the simultaneous acute kidney injury (creatinine 9 mg/dL, BUN 85 mg/dL) with proteinuria and hematuria, bilateral pulmonary consolidations unresponsive to antibiotics, anemia, and rapid deterioration to ARDS requiring mechanical ventilation.

Differential Diagnoses

Primary Considerations (Pulmonary-Renal Syndromes)

• Anti-GBM disease (Goodpasture syndrome) – The combination of diffuse alveolar hemorrhage (bilateral consolidations on imaging, anemia with hemoglobin 9 g/dL, basilar crackles) and rapidly progressive glomerulonephritis (creatinine 9 mg/dL from presumed baseline normal, proteinuria 100 mg/dL, RBC 10/hpf) in a young man is classic for anti-GBM antibody disease, which requires urgent plasmapheresis and immunosuppression to prevent irreversible renal failure and death. 1

• Granulomatosis with polyangiitis (GPA, formerly Wegener's) – ANCA-associated vasculitis presenting with pulmonary-renal syndrome is common; the neutrophilic leukocytosis (WBC 12,000/µL with neutrophil predominance) and elevated inflammatory markers (CRP 40 mg/L, ESR 20 mm/hr) support active vasculitis, though the absence of upper respiratory tract symptoms (sinusitis, epistaxis) makes this slightly less likely than anti-GBM disease. 1

• Systemic lupus erythematosus (SLE) with lupus nephritis and acute lupus pneumonitis – Young adults can present with simultaneous renal and pulmonary involvement; however, the rapid progression to respiratory failure requiring intubation within hours of admission is more typical of alveolar hemorrhage syndromes (anti-GBM or ANCA vasculitis) than lupus pneumonitis. 1

Secondary Considerations

• Acute interstitial pneumonia (Hamman-Rich syndrome) – This fulminant idiopathic form of diffuse alveolar damage presents with fever, cough, dyspnea progressing over days to weeks in a previously healthy individual, bilateral ground-glass opacities on CT, and rapid progression to ARDS with mortality exceeding 60%; however, it does not explain the severe acute kidney injury with proteinuria and hematuria. 1

• Severe community-acquired pneumonia with sepsis-induced AKI – While pneumonia can cause AKI through sepsis, hemodynamic instability, and inflammatory mediators, the degree of renal dysfunction (creatinine 9 mg/dL) with significant proteinuria (100 mg/dL) and hematuria (10 RBC/hpf) is disproportionate and suggests intrinsic glomerular disease rather than prerenal azotemia or acute tubular necrosis. 2, 3

• Azithromycin-induced acute interstitial nephritis – The patient received azithromycin 500 mg daily for 5 days two weeks prior; drug-induced AIN can present with fever, rash (not reported here), eosinophilia (not reported), and AKI, but it does not explain the bilateral pulmonary consolidations, alveolar hemorrhage pattern, or rapid respiratory failure. 4

• Pulmonary-renal syndrome secondary to chronic hypertension – The patient is hypertensive (BP 150/100 mmHg) and uncontrolled hypertension can cause hypertensive nephrosclerosis and left-heart failure with pulmonary edema; however, the CT findings of "gray, hazy, white patches with increased lung density and visible underlying vessels" describe ground-glass opacities typical of alveolar hemorrhage or organizing pneumonia, not the interstitial edema and Kerley B lines of cardiogenic pulmonary edema, and the pulmonary artery wedge pressure would be elevated (>15 mmHg) in left-heart disease, which is inconsistent with the clinical picture. 1, 5

• Pulmonary veno-occlusive disease (PVOD) – PVOD can present with dyspnea, bilateral ground-glass opacities, and pulmonary hypertension, but it is rare, typically progresses over months, and does not cause acute kidney injury with glomerulonephritis. 1, 6

• Chronic thromboembolic pulmonary hypertension (CTEPH) – CTEPH produces dyspnea and pulmonary hypertension but is characterized by organized thrombi obstructing pulmonary arteries, not bilateral consolidations, and does not explain the acute kidney injury. 1, 6

Most Likely Diagnosis

Anti-GBM disease (Goodpasture syndrome) is the leading diagnosis because:

• The simultaneous onset of diffuse alveolar hemorrhage (bilateral consolidations, anemia, hemoptysis risk) and rapidly progressive glomerulonephritis (creatinine 9 mg/dL, proteinuria, hematuria) is pathognomonic for pulmonary-renal syndrome. 1

• The rapid deterioration to ARDS requiring intubation within hours reflects massive alveolar hemorrhage, which is life-threatening and requires urgent plasmapheresis. 1, 3

• The failure to respond to broad-spectrum antibiotics excludes bacterial pneumonia as the primary process. 7, 3

• The parental history of pulmonary tuberculosis is a red herring; while TB can cause pulmonary disease, it does not produce acute glomerulonephritis with this tempo, and the parents completed treatment. 1

• The absence of upper respiratory symptoms (sinusitis, epistaxis, nasal ulcers) makes GPA less likely, though it remains a close differential. 1

Urgent Diagnostic Steps

• Serum anti-GBM antibodies (by ELISA) – Positive in >90% of anti-GBM disease; results available within 24–48 hours. 1

• Serum ANCA panel (c-ANCA/PR3 and p-ANCA/MPO) – Positive in GPA (c-ANCA/PR3) or microscopic polyangiitis (p-ANCA/MPO); approximately 10–30% of anti-GBM patients are also ANCA-positive (double-positive disease with worse prognosis). 1

• Renal biopsy – Shows linear IgG deposition along the glomerular basement membrane on immunofluorescence in anti-GBM disease; crescentic glomerulonephritis with pauci-immune pattern in ANCA vasculitis. 1

• Bronchoscopy with bronchoalveolar lavage (BAL) – Progressively bloodier aliquots and hemosiderin-laden macrophages confirm alveolar hemorrhage; quantitative bacterial cultures exclude ventilator-associated pneumonia if performed before antibiotic escalation. 7, 3

• ANA, anti-dsDNA, complement levels (C3, C4) – Screen for SLE; low complement with positive anti-dsDNA supports lupus nephritis. 1

• Urinalysis with microscopy – RBC casts are pathognomonic for glomerulonephritis and distinguish it from prerenal azotemia or acute tubular necrosis. 2

Immediate Management

• Urgent plasmapheresis – Initiate within 24 hours for suspected anti-GBM disease or severe ANCA vasculitis with pulmonary hemorrhage; delays beyond 48 hours reduce the likelihood of renal recovery and increase mortality. 1

• High-dose intravenous methylprednisolone (500–1000 mg daily for 3 days) followed by oral prednisone (1 mg/kg/day) – Suppresses inflammation and antibody production. 1

• Cyclophosphamide (2 mg/kg/day oral or 15 mg/kg IV pulse every 2 weeks) or rituximab (375 mg/m² weekly × 4 doses) – Induces remission in ANCA vasculitis and anti-GBM disease; rituximab is preferred in young men to avoid cyclophosphamide-related infertility. 1

• Lung-protective mechanical ventilation – Target tidal volume 6 mL/kg predicted body weight, plateau pressure <30 cmH₂O, and PEEP titrated to maintain oxygenation while minimizing ventilator-induced lung injury; higher PEEP levels (>15 cmH₂O) are independently associated with acute kidney injury and should be avoided when possible. 8, 3

• Renal replacement therapy (hemodialysis) – Indicated for uremia (BUN 85 mg/dL, creatinine 9 mg/dL), hyperkalemia, metabolic acidosis, or volume overload refractory to diuretics. 2, 4

• Blood-pressure control – Target <130/80 mmHg to reduce further renal injury; avoid ACE inhibitors or angiotensin-receptor blockers in acute kidney injury with oliguria, as they can worsen hyperkalemia and azotemia. 2

Common Pitfalls

• Assuming all bilateral pulmonary infiltrates with fever are pneumonia – The lack of response to antibiotics, simultaneous acute kidney injury with glomerulonephritis, and rapid progression to ARDS should immediately trigger consideration of pulmonary-renal syndromes. 1, 3

• Delaying plasmapheresis pending biopsy results – In life-threatening alveolar hemorrhage, empiric plasmapheresis and immunosuppression should begin immediately after serum is drawn for anti-GBM and ANCA antibodies; waiting for biopsy confirmation can result in irreversible renal failure or death. 1

• Attributing acute kidney injury to sepsis or prerenal azotemia – The presence of proteinuria (100 mg/dL), hematuria (10 RBC/hpf), and disproportionate creatinine elevation (9 mg/dL) indicates intrinsic glomerular disease, not hemodynamic AKI. 2, 4

• Overlooking the parental TB history as a clue to immune dysregulation – While the parents' TB is treated, chronic immune activation or genetic predisposition to autoimmune disease may be relevant; however, TB itself does not cause acute glomerulonephritis. 1

• Using high PEEP (>15 cmH₂O) without considering renal consequences – Elevated PEEP independently increases the risk of acute kidney injury in ARDS patients; balance oxygenation goals with renal protection. 8